• Aucun résultat trouvé

[PDF] Top 20 The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review

Has 10000 "The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review" found on our website. Below are the top 20 most common "The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review".

The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review

The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review

... interest in whether treatment with TNF inhibitors further increases the risk of lymphoma in patients with ...Following the issuing of a US Food and Drug ... Voir le document complet

29

Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis.

Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis.

... associated in some cases with “paradoxical” systemic sarcoidosis [3] but only two cases of neurosarcoidosis have been reported and none with ...occurred in another RA female patient treated by ... Voir le document complet

4

Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature

Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature

... summarizes the main aspects of the PGA and key messages presented in this ...using a 0–10 VAS. Therefore, PGA plays a major role in determining fulfillment of remission ... Voir le document complet

12

Improvements in Fatigue in 1536 Patients with Rheumatoid Arthritis and Correlation with Other Treatment Outcomes: A Post Hoc Analysis of Three Randomized Controlled Trials of Abatacept

Improvements in Fatigue in 1536 Patients with Rheumatoid Arthritis and Correlation with Other Treatment Outcomes: A Post Hoc Analysis of Three Randomized Controlled Trials of Abatacept

... fatigue in RA are not com- pletely ...Although a recent systematic review showed no correlation between fatigue and disease dura- tion in RA, significant correlations were repor- ted between ... Voir le document complet

12

Physical Activity Assessment Using an Activity Tracker in Patients with Rheumatoid Arthritis and Axial Spondyloarthritis: Prospective Observational Study

Physical Activity Assessment Using an Activity Tracker in Patients with Rheumatoid Arthritis and Axial Spondyloarthritis: Prospective Observational Study

... Although patients were not instructed to perform more physical activity, they get feedback on their activity and may have increased it, because of the motivational aspect of the activity tracker ... Voir le document complet

16

Fears and Beliefs in Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Study

Fears and Beliefs in Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Study

... diseases, the variability and unpredictability of the disease course and the disabling nature of the symptoms means that these diseases have a significant negative impact on quality of ... Voir le document complet

17

Where to Stand with Stromal Cells and Chronic Synovitis in Rheumatoid Arthritis?

Where to Stand with Stromal Cells and Chronic Synovitis in Rheumatoid Arthritis?

... RA patients become senescent upon chronic self-antigen exposure and express p16 INK4a , p21 CDKN1a and CD57, but also accumulate DNA damage and telomere defects (for review [ 16 , 67 ...]). The ... Voir le document complet

12

Targeted proteomics reveals serum amyloid A variants and alarmins S100A8-S100A9 as key plasma biomarkers of rheumatoid arthritis

Targeted proteomics reveals serum amyloid A variants and alarmins S100A8-S100A9 as key plasma biomarkers of rheumatoid arthritis

... of the SAA variants levels in controls ( Fig. 5 ). On the contrary, complex correlations were observed in ...correlated with SAA2 concentrations in the 3 stages of RA, ... Voir le document complet

11

Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial

Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial

... performed with the combi- nation of adalimumab and MTX as the reference ...for the following dichotomous end points: ACR20, 50, 70 responses, moderate and good EULAR responses, and ...and ... Voir le document complet

8

Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease

Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease

... consecutive patients with RA, >18 years of age, from 3 tertiary rheumatology centers (Paris, France, Tokyo, Japan and Zurich, Switzerland) over a 36-month ...All patients fulfilled ... Voir le document complet

12

Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients

Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients

... Sir, In rheumatoid arthritis (RA), regular assessment of disease activity is an integral part of a treat-to-target ...consultations with the rheumatologist are not always ... Voir le document complet

5

Patient-Physician Discordance in Global Assessment in Rheumatoid Arthritis: A Systematic Literature Review With Meta-Analysis

Patient-Physician Discordance in Global Assessment in Rheumatoid Arthritis: A Systematic Literature Review With Meta-Analysis

... as a continuous value but it is also of course possible to analyse patient-physician discordance using the absolute difference with different cut-offs as a binary ...PhGA with a ... Voir le document complet

23

Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort

Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort

... assessment The following data were collected at baseline and at each visit: demographic data, comorbidities, current tobacco use, current alcohol consumption, family history of RA, duration of symptoms at ... Voir le document complet

10

Treatment of active rheumatoid arthritis : comparison between young and elderly patients (corpus cohort)

Treatment of active rheumatoid arthritis : comparison between young and elderly patients (corpus cohort)

... séparé. A Soraya, d’avoir corrigé pendant des heures mon anglais, ta patience et ta curiosité à essayer de comprendre mon travail malgré le fait que nous ne travaillons pas du tout dans le même ... Voir le document complet

33

Missing data in randomized controlled trials of rheumatoid arthritis with radiographic outcomes: A simulation study.

Missing data in randomized controlled trials of rheumatoid arthritis with radiographic outcomes: A simulation study.

... L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignemen[r] ... Voir le document complet

26

Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis.

Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis.

... proposed a model of the SE component in RA ...reconsidered the SE hypothesis and generated a new classi- fication of HLA-DRB1 alleles, based on their investigation using the MASC ... Voir le document complet

7

Autoantibodies to BRAF, a new family of autoantibodies associated with rheumatoid arthritis

Autoantibodies to BRAF, a new family of autoantibodies associated with rheumatoid arthritis

... enter the cell later as immune ...domains. The N terminal domain is responsible for the fixation of BRAF to ...RAS. The C terminal domain contains the sub- strate recognition sequence ... Voir le document complet

8

Data access, a driver of innovation in the biophanrmaceutical sector: a focus on rheumatoid arthritis

Data access, a driver of innovation in the biophanrmaceutical sector: a focus on rheumatoid arthritis

... Given the diversity across the broader healthcare ecosystem, most of the participants interviewed were in agreement that building trust among stakeholders is a priority [r] ... Voir le document complet

76

Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis

Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis

... associated with subsequent response to RTX at week 24 in the combination of cohorts 1 and 2 Multivariate analyses indicated that four factors were independently and significantly associated ... Voir le document complet

9

In Antisynthetase Syndrome, ACPA Are Associated With Severe and Erosive Arthritis: An Overlapping Rheumatoid Arthritis and Antisynthetase Syndrome

In Antisynthetase Syndrome, ACPA Are Associated With Severe and Erosive Arthritis: An Overlapping Rheumatoid Arthritis and Antisynthetase Syndrome

... is the first case–control study to assess the clinical significance of ACPA in patients with ASS, suggests that ASS-patients with ACPA have an overlapping RA–ASS ... Voir le document complet

9

Show all 10000 documents...